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Abstract
We previously demonstrated that the initial emergence of endocardial precursor cells (endocardial angioblasts) occurred within the
precardiac mesoderm and that the endodermal secretory products promoted delamination of cells from the precardiac mesoderm and
expression of endothelial lineage markers [Dev. Biol. 175 (1996), 66]. In this study, we sought to extend our original study to the
identification of candidate molecules derived from the endoderm that might have induced endocardial precursor cell formation. We have
detected expression of transforming growth factors  (TGF) 2, 3, and 4 in anterior endoderm at Hamburger and Hamilton (H-H) stage 5
by RT-PCR. To address the role of growth factors known to be present in the endoderm, precardiac mesodermal explants were isolated from
H-H stage 5 quail embryos and cultured on the surface of collagen gels with serum-free defined medium 199. Similar to the effect of explants
cocultured with anterior endoderm, when cultured with TGFs 1–3 (3 ng/ml each), explants formed QH-1 (anti-quail endothelial
marker)-positive mesenchymal cells, which invaded the gel and expressed the extracellular marker, cytotactin (tenascin). Another member
of the TGF superfamily, bone morphogenetic protein-2 (BMP-2; 100 ng/ml), did not induce QH-1-positive mesenchymal cell formation
but promoted formation of an epithelial monolayer on the surface of the collagen gel; this monolayer did not express QH-1. Explants treated
with vascular endothelial growth factor (VEGF165, 100 ng/ml) also did not invade the gel but formed an epithelial-like outgrowth on the
surface of the gel. However, this monolayer did express the QH-1 marker. Fibroblast growth factor-2 (FGF-2; 250 ng/ml)-treated explants
expressed QH-1 and exhibited separation of the cells on the surface of the gel. Finally, a combination of TGFs and VEGF enhanced
formation of QH-1-positive cord-like structures within the gel from mesenchyme that had previously invaded the gel. Luminization of the
cords, however, was not clearly evident. These findings suggest that TGFs, among the growth factors tested, mediate the initial step of
endocardial formation, i.e., delamination of endothelial precursor cells from precardiac mesoderm, whereas VEGF may primarily effect
early vasculogenesis (cord-like structure formation).
© 2003 Elsevier Inc. All rights reserved.
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Introduction
The primary heart tube in all vertebrates consists of inner
and outer cardiac epithelial walls, endocardium, and myo-
cardium. Evidence from in vivo tracing (Garcia-Martinez
and Schoenwolf, 1993) and fate mapping experiments (Stal-
sberg and DeHaan, 1969) in early chick embryos has indi-
cated that the endocardial and myocardial lineages may
arise from the precardiac mesoderm. Retroviral-mediated
lineage tracing studies have also indicated that both endo-
cardial and myocardial precursor cells are present in the
heart-forming regions of HH stage 4/5 chick embryos (Co-
hen-Gould and Mikawa, 1996). These findings confirm that
at least one cohort of endocardial precursor cells derives
from the precardiac mesoderm as initially suggested by
Sabin (1920).
While considerable descriptive information has been ob-
tained delineating the development of the endocardium,
there have been few experiments that address the mecha-
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nisms regulating this process (for reviews, see Baldwin,
1996; Fishman and Chien, 1997; Lough and Sugi, 2000).
During its initial formation, following gastrulation and until
incorporation into a tubular heart, the precardiac mesoderm
is continuously associated with anterior lateral plate
endoderm. Ablation and/or transplantation studies have pro-
vided considerable evidence that the endoderm has an in-
structive or permissive role in myocardiogenesis (reviewed
by Jacobson and Sater, 1988; Sugi and Lough, 1994; Nas-
cone and Mercola, 1995; Schultheiss et al., 1995; Lough and
Sugi, 2000), hematopoietic cell formation, and vascular
endothelial cell differentiation (Wilt, 1965; Pardanaud and
Dieterlen-Lievre, 1999). However, except for our previous
study which indicated that anterior lateral plate endoderm
promoted endocardial endothelial precursor cell formation
from the precardiac mesoderm (Sugi and Markwald, 1996),
there have been few studies into the origin and regulation of
endocardiogenesis.
In this study, we sought to extend our original study to
determine candidate molecules derived from the endoderm
that might have mediated endodermal signaling on precar-
diac mesoderm. Because polypeptide growth factors fre-
quently mediate embryonic induction, we sought to test the
hypothesis that endodermally derived growth factors induce
formation of endocardial precursor cells and their assembly
into vascular structures. The selection of growth factors was
based on their expression or presence in the endoderm at the
appropriate developmental window to interact with precar-
diac mesoderm.
Among those factors selected were members of the trans-
forming growth factor s (TGFs) known to be expressed
in the endoderm at the mRNA level, i.e., TGF1 and 2 in
mice (Dickson et al., 1993; Roelen et al., 1994), and
TGF2, 3 (Jakowlew et al., 1994), and 4, a chick cognate
of mammalian 1 (Jakowlew et al., 1992), in chick. Type II
TGF receptor, which is critical and constitutively essential
for all TGF signaling (Wrana et al., 1994), is expressed in
embryonic avian endothelial cells (Brown et al., 1996,
1999b). Endoglin, an ancillary TGF receptor, has also
been detected in endocardial endothelial cells (Vincent et
al., 1998). The importance of TGF signaling in endothelial
cell formation and differentiation has been emphasized by
the mutation of the TGF type II receptor, which caused
defects in yolk sac vasculature and hematopoiesis (Oshima
et al., 1996). Similar defects were reported in endoglin
mutant mice (Arthur et al., 2000) and were consistent with
those seen in TGF1 ligand knock out mice (Dickson et al.,
1995).
Another TGF superfamily member, bone morphoge-
netic protein-2 (BMP-2), is also expressed in the endoderm
adjacent to precardiac mesoderm (Schultheiss et al., 1997;
Andre´e et al., 1998; Ehrman and Yutzey, 1999). Receptors
for BMPs, e.g., activin receptor IIA (ActR-IIA) (Stern et al.,
1995) and BMP receptor 1B (BMPR-IB) (Lough and Sugi,
2000), are expressed in precardiac mesoderm at the mRNA
level. Thus, the role of BMP-2 in endocardiogenesis was
also investigated in this study.
We have included vascular endothelial growth factor
(VEGF) in this study since it also has been demonstrated to
be expressed in the endoderm of mouse embryos (Breier et
al., 1995) and quail embryos (Flamme et al., 1995). VEGF
and its receptors, VEGFR-1 (Flt-2) and VEGFR-2 (Flk-1,
also known as KDR in human), may have an important
function in differentiation of the endothelial lineage (Breier
et al., 1995; Shalaby et al., 1995; Fong et al., 1995). Tar-
geted inactivation of the genes encoding VEGF and its
receptors resulted in defective vascular development and
early embryonic lethality (Fong et al., 1995; Shalaby et al.,
1995; Carmeliet et al., 1996; Ferrara et al., 1996). Fibroblast
growth factor-2 (FGF-2) protein and mRNA, also detected
in early chick endoderm, (Parlow et al., 1991; Sugi et al.,
1993), have been implicated to play an important role in
endothelial differentiation through their receptors (Flamme
and Risau, 1992; Krah et al., 1995, Friesel and Maciag,
1995; Baldwin et al., 1996). Finally, recent assays using
beads soaked with exogenous FGF-2 implanted into the
somitic mesoderm of avian embryos suggested a direct role
for FGF-2 in vasculogenesis/angiogenesis (Cox and Poole,
2000; Poole et al., 2001).
To study the regulation of early endocardial formation,
we have established a primary culture system which reca-
pitulates endocardiogenesis from precardiac mesoderm us-
ing a collagen gel culture assay (Sugi and Markwald, 1996).
Using this assay system, we now show that (1) TGFs but
not BMP-2 promoted endocardial precursor cell formation
from precardiac mesoderm cultured on the collagen gel as
evidenced by QH-1 (quail endothelial marker)-positive in-
vasive mesenchymal cell formation and expression of the
extracellular marker cytotactin (tenascin); (2) Neither
VEGF nor FGF-2 promoted invasive mesenchymal cell
formation. However, VEGF enhanced formation of a QH-
1-positive epithelial monolayer from precardiac mesoderm;
(3) FGF-2 induced only separation of the cells on the sur-
face of the gels; (4) Combination of TGFs and VEGF
enhanced formation of cord-like structures of QH-1-positive
cells within the collagen gel. These findings suggest that
TGFs can mediate endocardial precursor cell formation
from mesoderm, i.e., the delamination of endothelial pre-
cursor cells from precardiac mesoderm and expression of
endothelial marker protein, whereas VEGF primarily effects
early vasculogenesis. Portions of this work were previously
reported in an abstract form (Sugi and Markwald, 1998).
Materials and methods
Embryos
Fertilized eggs from Japanese quail (Coturnix coturnix
japonica) were incubated in a humid atmosphere at 38°C.
Stages of embryonic development were determined by us-
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ing the criteria made for chick embryos by Hamburger and
Hamilton (1951).
Detection of transforming growth factor expression from
endoderm by reverse transcription–polymerase chain
reaction (RT-PCR)
The expression of TGFs was detected by RT-PCR. This
assay was employed because endoderm from the cardio-
genic region in each Hamburger and Hamilton (H-H) stage
5 quail embryo contained approximately 4000–5000 cells.
Total RNA from H-H stage 5 endoderm was purified by
using RNAzol (Tel-Test, Inc.; Chomczynski and Sacchi,
1987). Complementary DNA was prepared by using oligo-
dT-primed MMLV reverse transcriptase (Promega). The
cDNA was amplified by using Thermus aquaticus (Taq)
DNA polymerase with 30 cycles of denaturation (94°C, 1
min), primer annealing (55°C, 1.5 min), and extension
(72°C, 2 min). Primers were carefully designed to chicken
TGF-2 (Jakowlew et al., 1990), chicken TGF-3 (Ja-
kowlew et al., 1988a), and chicken TGF-4 (Jakowlew et
al., 1988b). The primer pair for TGF2 was 5-CAT-CTC-
CAT-CTA-CAA-CAG-CAC-C-3 (forward primer) and 5-
GCA-TTT-TTC-TCC-ATC-GCC-3 (reverse primer). The
primer pair for TGF3 was 5-AGG-AGA-TGG-AGG-
AGG-AGA-AG-3 (forward primer) and 5-AAG-CGG-
AAC-ACA-TTG-GAG-3 (reverse primer). The primer pair
for TGF4 was 5-ATG-AGT-ATT-GGG-CCA-AAG-3
(forward primer) and 5-ACG-TTG-AAC-ACG-AAG-
AAG-3 (reverse primer). That the predicted PCR products,
219 bp of TGF-2, 160 bp of TGF-3, and 109 bp of
TGF-4, were not amplified from genomic DNA was ver-
ified by treating samples with RNase-free DNase-1 (Pro-
mega) before reverse transcription. As a positive control for
the PCR, a 241-bp sequence of chick cytoplasmic -actin
was also amplified by using primers prepared according to
the sequence published by Kost et al. (1983). The primer
pair for cytoplasmic actin was 5-GTA-CTC-TGT-CTG-
GAT-TGG-3 (forward primer) and 5-TAA-TCC-TGA-
GTC-AAG-CGC-3 (reverse primer). All of the primers
were purchased from Life Technologies (New York, NY).
After the purification by QIAquick spin columns (QIA-
GEN), the PCR products were verified by thermal cycle
sequencing using Taq DNA polymerase and fluorescent
dye-labeled terminations (Medical University of South
Carolina, Biotechnology Resource Laboratory).
Serum-free culture of cardiogenic mesoderm
Microdissection and culturing procedure have previously
been described in detail (Sugi et al., 1993; Sugi and Lough,
1994; Sugi and Markwald, 1996). Briefly, stage 5 quail
embryos were treated with 1 mg/ml collagenase/dispase
(Boehringer-Mannheim, Indianapolis), in Ca2- and Mg2-
free phosphate-buffered saline (PBS) to loosen the connec-
tions between germ layers. Enzyme reaction was stopped by
the 0.02% EDTA/PBS. Serum was not used in any phase of
tissue isolation or culturing. Sheets of anterior lateral plate
mesoderm, corresponding to the endocardial fate map
(Stalsberg and DeHaan, 1969) shown in Fig. 1, were mi-
crodissected with tungsten needles. Each explant was plated
on a hydrated collagen gel containing fibronectin (1.0
mg/ml rat tail tendon type I collagen, Collaborative Re-
search, and 10 g/ml bovine plasma fibronectin, Sigma).
After attachment of the explants to the surface of the col-
lagen gel, serum-free defined medium M 199 (GIBCO/
BRL) supplemented with 5 g/ml insulin, 5 g/ml trans-
ferrin, and 5 ng/ml selenium (ITS, Collaborative Research),
100 unit/ml penicillin and 100 g/ml streptomycin (SFM)
was added and changed daily. For some experiments, to
produce endoderm-conditioned medium, anterior lateral
plate endoderm was explanted on the surface of a Coster
nucleopore filter (Transwell, 0.4-m pore size, Costar,
Cambridge, MA) that was overlaid on a collagen gel as
detailed in Sugi and Markwald (1996). The depth of the
Costar apparatus provided a final 1.0-mm space filled with
culture medium between endoderm and mesoderm. There-
fore, in the Costar system, there was no direct attachment of
endoderm cultured on the top of the filter and the mesoderm
cultured on the surface of the gel and soluble factors se-
creted by the endoderm could go through the 0.4-m pore.
TGFs, FGF-2, and VEGF165 were purchased from
R&D Systems. Recombinant human BMP-2 was kindly
provided by Genetics Institute (Cambridge, MA). SFM in-
cluding either porcine TGF-1, -2, and -3 (3 ng/ml
each); recombinant human FGF-2 (250 ng/ml); recombinant
human VEGF165 (100 ng/ml); or BMP-2 (100 ng/ml) was
added individually or in combination after the explants
attached to the collagen gel (2 h). Media, including growth
factors, were changed daily, and morphological analysis of
cultured mesoderm was performed every 24 h by using an
inverted microscope equipped with Hoffman Optics (Olym-
pus, IMT-2). Cultured explants were scored positive for
invasive mesenchymal cell formation based on detection of
at least five cells underneath the surface of the collagen gel
on day three of culture.
Immunostaining of cultured explants on the collagen gel
Cultured explants in the collagen gel were rinsed with
phosphate-buffered saline (PBS) and fixed with 100% cold
(20°C) methanol, then rehydrated through a graded meth-
anol series. After a brief wash with distilled water, samples
were rinsed with PBS and incubated with 10% normal goat
serum in 1% bovine serum albumin (BSA)–PBS to block
nonspecific binding for 1 h at 4°C. For double immuno-
staining, MF20 immunostaining was performed first at 4°C
overnight. After rinsing with 1% BSA–PBS, the samples
were incubated with RITC-labeled goat anti-mouse IgG
(Organon Teknika Corp.), which was followed by 10%
normal goat serum/1% BSA–PBS for blocking. The sam-
ples were then stained with either QH-1 or antibodies to
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cytotactin (generous gift from Dr. Stanley Hoffman, Med-
ical University of South Carolina) followed by an incuba-
tion with FITC-labeled antibodies, goat anti-rabbit IgG for
cytotactin, and goat anti-mouse IgG for QH-1. Samples
were rinsed and mounted with DABCO (Sigma)/90% glyc-
erol in PBS. Immunostained samples were observed under a
Zeiss Axioskope fluorescent microscope.
Results
TGFs are expressed in the heart forming endoderm
To evaluate the expression of TGFs in heart-forming
anterior lateral plate endoderm, endodermal tissue from
stage 5 embryos (Fig. 1) was microdissected and applied for
RT-PCR. Messenger RNAs for TGF2, 3, and 4 were
detected from stage 5 endoderm (Fig. 2). These results
confirm that the expected inducer, anterior lateral plate
endoderm, is the source of TGFs. Semiquantitatively, Fig.
2 indicates that relatively high levels of TGF2 and 3 are
expressed in the anterior lateral plate endoderm.
Morphological effects of TGFs, BMP-2, FGF-2, and
VEGF
Our previous data indicate that endocardial precursor
cells are derived, at least in part, from the precardiac me-
soderm. At stage 5, the precardiac mesoderm is composed
of two to three cell layers of undifferentiated cells that have
no detectable characteristics of either myocardial or endo-
thelial lineages, e.g., neither the endocardial marker QH-1
nor the myocardial marker MF20 has been detected. Using
collagen gels and explants of stage 5 precardiac mesoderm,
we sought to determine whether any of the selected growth
factors known to be present in endoderm could simulate the
effect of endodermal tissue on early endocardial formation.
Fig. 1. Source of precardiac mesodermal explants. Heart-forming meso-
derm was microdissected from anterior lateral plate of a stage 5 quail
embryo based on stage 5 chick endocardial fate map (lines indicate each
segment of the heart at stage 12, after Stalsberg and DeHaan, 1969).
Diagram shows a transverse section at the level of the heart-forming region
at stage 5, illustrating the germ layers used for the culture assays.
Fig. 2. Expression of TGFs-2, 3, and 4 mRNA was detected by RT-PCR
from stage 5 quail endoderm. Total RNA was purified and reverse tran-
scribed, and the resultant cDNA was amplified by using primers that
specify 219 bp of TGF2 (2), 160 bp of TGF3 (3), 109 bp of TGF4
cDNA, and, as a positive control for PCR, 245-bp sequence of cytoplasmic
-actin (cy). Lanes 1 and 6, respectively, contained 123-bp and 1-kbp
ladder size markers. The PCR products were verified by thermal cycle
sequencing.
Fig. 3. Morphological effects of endoderm-conditioned medium or growth factors on precardiac mesodermal explants from stage 5 quail embryos cultured
on the surface of collagen gels. Mesodermal explants from stage 5 quail embryos were cultured on the surface of collagen gels in (a) serum-free-defined
medium M199 supplemented with ITS alone (SFM), (b) endoderm-conditioned medium, (c) VEGF165, (d) TGFs-1, 2, and 3, (e) FGF-2, (f) TGF s and
VEGF, or (g) BMP-2. (a) Mesoderm cultured with SFM was smaller in size, stayed on the surface of the gel, and exhibited no invasion. (b) Endoderm-
conditioned medium promoted invasive mesenchymal cell formation from the mesoderm. (c) VEGF-treated mesoderm formed an epithelial monolayer on
the surface of the gel. (d) Mesoderm treated with TGFs formed mesenchymal cells which invaded collagen gels. (e) FGF-2 caused only separation of the
mesodermal cells on the surface of the gel. (f) Combination of TGFs and VEGF enhanced formation of cord-like structures from invaded mesenchymal cells
(arrows). (g) BMP-2-treated mesoderm formed only an epithelial monolayer on the surface of the gel. In each of the above treatments, contractile tissue was
always formed as a three dimensional mass of the cells on the surface of the gel (M). Explants were photographed by using Hoffman optics. Scale bars, 200
m.
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When treated with endodermal conditioned medium, which
is produced by the Costar Transwell apparatus (see details
in Materials and methods), many mesodermal cells invaded
the collagen gel, becoming free mesenchymal cells (Fig.
3b). Conversely, serum-free-defined medium supplemented
only with ITS (SFM) failed to induce invasive mesenchy-
mal cell formation from the mesoderm, and aggregates of
undifferentiated mesodermal cells remained on the surface
of the gels (Fig. 3a). Similar to the effect of endodermal
conditioned medium, TGF1, 2, and 3 (3 ng/ml each,
porcine recombinant) treatment of mesoderm in the absence
of endoderm resulted in both formation of a contractile mass
of cells on the surface of the gel, indicating myocardial
differentiation, and free mesenchymal cells which invaded
the collagen lattice (Fig. 3d), potentially representing early
endocardial precursor cells. Importantly, when TGF1, 2,
or 3 was added individually to the mesoderm singularly at
a final concentration of 3 ng/ml, the same effects were
found, including formation of free mesenchymal cells that
invaded the collagen gel (data not shown). However, an-
other TGF superfamily member, BMP-2 (100 ng/ml), was
unable to induce invasive mesenchymal cell formation but
Fig. 6. Quantitative summary of invasive mesenchymal cell formation in growth factor-treated precardiac mesoderm. Stage 5 quail precardiac mesodermal
explants were cultured with serum-free-defined medium M199 (SFM). Cultured explants were scored positive for invasive mesenchymal cell formation based
on detection of more than five cells beneath the plane of the collagen gel surface. When cultured with TGF1–3 or TGF1–3 VEGF, similar to the effect
of endoderm-conditioned medium, invasive mesenchymal cell formation was evident. By contrast, FGF-2, BMP-2, and VEGF individually did not support
invasive mesenchymal cell formation. The number in parenthesis indicates the number of explants that were evaluated.
Fig. 4. MF20 and QH-1 double immunostaining of precardiac mesodermal explants from stage 5 quail embryos cultured on the surface of collagen gels. Phase
contrast (a, b, c, d, e, f, g) and QH-1 (FITC, green color), MF20 (RITC, reddish yellow color) double immunofluorescence (a, b, c, d, e, f, g, h, i)
microscopy of mesodermal explants. (a) Mesoderm cultured with SFM did not express QH-1. (b) When cultured with endoderm-conditioned medium,
mesenchymal cells invaded into collagen gels and expressed QH-1 antigen. (c) VEGF-treated mesoderm exhibited small perinuclear QH-1 staining within
the epithelial monolayer that formed on the surface of the gel but mesenchymal cell formation did not occur. (d) By contrast, the mesoderm cultured with
TGFs formed QH-1-positive mesenchymal cells which invaded the gel lattice. (e) FGF-2-treated mesoderm did exhibit QH-1 staining in cells that separated
from each other. These cells did not invade the gel lattice. (f) In mesoderm treated with TGFs  VEGF, QH-1-positive cord-like vascular structures were
formed within the gel (arrows). (g) BMP-2-treated mesodermal epithelial monolayers did not express QH-1. Note the difference between epithelial cells
treated with VEGF and BMP-2. In each of the above, MF20-positive myocardial cells were formed as a three-dimensional mass of the cells on the surface
of the collagen (M). An MF20-positive contractile mass of the cells is always formed after the treatment of FGF-2. However, the particular sample presented
in Fig. 4e lost the mass of the cells which grew on the surface of the gel during the whole-mount immunohistochemistry procedure. (h) Higher magnification
view of (c). This figure clearly indicates punctate perinuclear QH-1 staining within the VEGF-treated mesodermal cells (arrows). (i) Unlike VEGF-treated
mesodermal cells, FGF-treated mesodermal cells showed more broad cytoplasmic-staining (arrow heads) similar to that observed in the cells treated with
endoderm-conditioned medium or TGFs. Scale bar, 100 m.
Fig. 5. MF20 and cytotactin double immunostaining of precardiac mesodermal explants from stage 5 quail embryos cultured on the surface of collagen gels.
Phase contrast (a, b, c, d, e, f, g) and cytotactin (FITC, green color), MF20 (RITC, reddish yellow color) double immunofluorescence (a, b, c, d, e, f,
g) microscopy of mesodermal explants. Mesoderm cultured alone in SFM remained epithelial and did not express cytotactin (a). Cytotactin staining was
observed only after treatments that induced invasive mesenchymal cell formation, i.e., endoderm-conditioned medium (b), TGFs (d), or TGF  VEGF
(f), but not VEGF (c), FGF-2 (e), or BMP-2 (g). In each of the above experiments, MF20-positive myocardial cells were formed as three-dimensional
mass of the cells on the surface of the gel (M). Scale bar, 100 m.
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did promote the outgrowth of an epithelial cell monolayer
on the surface of the collagen gel (Fig. 3g). Precardiac
mesodermal explants treated with VEGF165 (100 ng/ml)
also did not give rise to cells that invaded into the gel but
rather to cells that formed an epithelial monolayer on the
surface of the gel (Fig. 3c). FGF-2 (200 ng/ml)-treated
mesodermal explants formed a loose surface monolayer in
which cells were partially separated from one another but
did not from invasive mesenchymal cells (Fig. 3e). Thus,
only TGF treatment was effective in promotion of invasive
cells from a stage 5 mesodermal explant. When TGFs
were combined with VEGF, the cells that invaded the gel
formed cord-like (vascular) structures within the gel lattice
(Fig. 3f), which could not be enhanced or diminished by
addition of either FGF-2 or BMP-2.
Endothelial marker, QH-1 expression in growth factor-
treated precardiac mesoderm
At the onset of culture, stage 5 mesoderm does not
express a QH-1 endothelial marker. In vivo findings (Coffin
and Poole, 1988; Sugi and Markwald, 1996) indicate that
QH-1 expression initially occurs in free mesenchymal cells
associated with precardiac mesoderm at stage 7. In the
present study, precardiac mesoderm cultured with SFM
(supplemented only with ITS) formed an MF 20-positive,
contractile mass of the cells on the surface of the gel,
indicating myocardial differentiation, but neither invasive
mesenchymal cell formation nor QH-1 expression was de-
tected (Fig. 4a and a). However, when cocultured with
endoderm or endodermal conditioned medium, many cells
Fig. 7. Summary diagram of culture assays using stage 5 quail mesoderm. Precardiac mesoderm treated with endoderm-conditioned medium (bottom center)
differentiated into contractile mass of cells on the surface of the collagen gel and numerous mesenchymal cells invaded the gel and expressed endothelial
marker QH-1 and the mesenchymal marker, cytotactin. Conversely, mesodermal explants cultured in serum-free M199 (SFM) alone (top center) remained
on the surface of the gels and expressed little, if any QH-1. TGF-treated explants resemble that of endoderm-conditioned medium treated, i.e., QH-1
expression and invasive mesenchymal cell formation. VEGF-treated explants formed epithelial monolayer on the surface of the gel, which express perinuclear
cytoplasmic staining of QH-1. BMP-2-treated explants formed QH-1-negative epithelial monolayer on the surface of the collagen gel. FGF-2-treated explants
exhibited only separation of the cells on the surface of the gel but no invasion of cells. Cytotactin expression was detected only after the treatment of
endoderm-conditioned medium, TGFs and TGF  VEGF, similar to the effect of endoderm. By contrast, FGF, VEGF, or BMP-2-treated explants did not
express cytotactin. In each of the treatments, MF-20-positive myocardial cells were formed as a three-dimensional mass of cells on the surface of the gel
presumably because of the insulin supplemented in the medium.
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migrated from the original explant, invaded the collagen
gel, and expressed QH-1 (Fig. 4b and b), in addition to
formation of an MF20-positive contractile mass at the sur-
face of the gels (M, yellow–red color in Fig. 4b). Similar to
the effect of endoderm, mesenchymal cells that invaded
collagen gels in response to TGFs also expressed a QH-1
endothelial marker (Fig. 4d and d). Epithelial monolayers
that formed in VEGF-treated precardiac mesoderm exhib-
ited a perinuclear punctate staining pattern for QH-1 (Fig.
4c, c, and arrows in Fig. 4h). This punctate staining pattern
is distinctively different from the uniform staining pattern
seen within invasive mesenchymal cells derived from the
mesodermal explants treated with endoderm-conditioned
medium or TGFs. By contrast, the monolayer that formed
in mesodermal explants treated with BMP-2 were QH-1-
negative (Fig. 4g and g), whereas FGF-2-treated mesoder-
mal cells, which were separated but stayed on the surface of
the gel, were QH-1-positive and showed similar cytoplas-
mic staining pattern to that of mesodermal cells treated with
endoderm-conditioned medium or TGFs. A punctate stain-
ing pattern which was seen in the cells treated with VEGF
was not observed in FGF-treated cells (Fig. 4e, and e, and
arrowheads in Fig. 4i). All of the above-mentioned stage 5
mesodermal explants, regardless of the type of treatment,
including just SFM, formed contractile masses on the sur-
face of the collagen gel that expressed MF20 (M, yellow–
red color in Fig. 4a, b, c, d, f, and g), a myocardial
differentiation marker protein. As Fig. 5e indicates, an
MF20-positive contractile mass of the cells is always
formed after the treatment of FGF-2. Myocardial differen-
tiation in the SFM was presumably supported by ITS (Sugi
and Lough, 1995).
Cytotactin (tenascin) expression in growth factor treated
precardiac mesoderm
Cytotactin is one of several mesenchymal marker pro-
teins expressed during early cardiac formation (Crossin et
al., 1986; Sugi and Markwald, 1996). Intense cytotactin
expression is revealed in the mesenchymal precursors of the
endocardium from stage 7 to stage 9. However, its expres-
sion is lost after mesenchymal cells become epithelialized to
form a definitive endocardial tube (Sugi and Markwald,
1996). Using cytotactin as a marker for mesenchymal cell
formation, we found that TGFs or TGF  VEGF treat-
ment induced cytotactin expression within invasive mesen-
chymal cells, which was similar to the effect of endoderm
(Fig. 5b, b, d, d, f, and f). By contrast, when added
individually, FGF-2-, VEGF-, or BMP-2-treated explants
did not express cytotactin up to 7 days of culture (Fig. 5a, a,
c, c, e, e, g, and g). In each of the above experiments, the
three-dimensional aggregates of contractile cells that had
grown on the surface of the gel were MF20-positive (M,
yellow–red color in Fig. 5a, b, c, d, e, f, and g).
Combination of TGFs and VEGF promote assembly of
preendothelial cells and formation of cord-like structures
When added in combination to the mesodermal explants,
VEGF and TGFs enhanced cell-to-cell association of in-
vaded QH-1-positive mesenchymal cells and the formation
of QH-1-positive cord-like structures (Figs. 3f, and 4f).
Such cord-like structure formation is typically seen in vivo
during early vasculogenesis. However, lumen formation
was not clearly evident in serial sections of paraffin embed-
ded mesodermal explants. These results are summarized in
Figs. 6 and 7, and Table 1.
Discussion
Endocardial precursor cell formation from precardiac
mesoderm
The differentiation process of endocardial precursor cells
from precardiac mesoderm has been well documented by
Linask’s group (Linask, 1992; Linask and Lash, 1993; Li-
nask et al., 1997). According to their description, at H-H
stage 5, precardiac mesoderm expresses the adhesion mol-
ecule N-cadherin evenly on all cell surfaces. During coelom
formation at around H-H stage 7–8, myocardial precursor
cells change shape and show a distinct polarity conveyed by
the apical expression of N-cadherin, lateral expression of
Na K ATPase, and enrichment of integrin on the basal
cell surface, indicating acquisition of an epithelial nature.
The endocardial precursor cells reside close to the
endoderm and eventually downregulate N-cadherin, which
Table 1
Differential effect of growth factors on formation of endocardial precursors explanted from precardiac mesoderm at H-H stage 5
Expression
phenotype
Treatment
Endoderm SFM TGFs BMP-2 FGF-2 VEGF TGF
VEGF
MF20       
QH-1      a 
Cytotactin       
Cell separation       
Cell seeding       
a QH-1 staining in VEGF-treated mesoderm is perinuclear punctate staining.
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correlated with endocardial cell sorting and aggregation
(Linask, 1992). Also, in culture assay experiments, Linask
and Lash (1993) described that the loss of N-cadherin ex-
pression by endocardial cells accompanied differentiation
and their eventual dissociation from N-cadherin-positive
myocardiocytes in mesodermal explants (Linask and Lash,
1993). In support of their finding, we found that stage 5
precardiac mesoderm did not express any endothelial
(QH-1) or myocardial (MF20) markers and expressed mes-
enchymal markers (cytotactin or JB-3 antigen, fibrillin-2)
weekly at H-H stage 5 (Sugi and Markwald, 1996). QH-1
expression and strong mesenchymal marker expression was
detected in the heart-forming region after H-H stage 7
(Sugi and Markwald, 1996). Taken together, these findings
suggest that, at H-H stage 5, the precardiac mesoderm is
undifferentiated, i.e., it expresses N-cadherin uniformly on
all cell surfaces, does not express any myocardial or endo-
cardial marker protein, and only weakly expresses mesen-
chymal marker proteins. However, after the onset of the
coelom formation at H-H stage 78, precardiac meso-
derm differentiates into (1) N-cadherin-positive-epithelial-
ized myocardial precursor cells in the splanchnic meso-
derm, which eventually express myocardial markers and (2)
endocardial precursor cells, which lose expression of N-
cadherin, delaminate from the future splanchnic mesoderm
by invading between the interface of endoderm and meso-
derm, and express endothelial (QH-1) and mesenchymal
(cytotactin and Fibrillin-2) markers. Upon examination of
transverse sections of paraffin-embedded chick embryos
and collagen gel cultured explants, undifferentiated precar-
diac mesodermal cells at stage 5 appear to be more cuboidal,
whereas endocardial precursor cells at stage 8 appear to be
more elongated and invasive (Sugi et al., 1995; Sugi and
Markwald, 1996). Thus, the endocardial precursor cell for-
mation from precardiac mesoderm is associated with a
change of cell shape and expression of marker proteins. In
the present study, by using a collagen gel culture system, we
have revealed that endoderm-conditioned medium or
TGFs induced this phenotypical change in mesodermal
explants, i.e., acquisition of invasive mesenchymal pheno-
type and expression of QH-1 endothelial and cytotactin
mesenchymal markers.
Endocardial precursor cell formation is recapitulated in
collagen gel cultured precardiac mesoderm
In summary, we propose that the following developmen-
tal progression occurs during formation of endocardium.
Epiblast cells that ultimately form endocardium and myo-
cardium migrate during stage 3 through the rostal half of the
primitive streak (Garcia-Martinez and Schoenwolf, 1993) to
form paired cohorts of cells at stage 5 within the anterior
lateral plate mesoderm, known as precardiac mesoderm
(Rawles, 1943; Rosenquist and DeHaan, 1966; Stalsberg
and DeHaan, 1969; Redkar et al., 2001). Thereafter, endo-
cardial precursors are segregated from myocardial precur-
sors, with the latter occupying the epithelial layer of the
splanchnic mesoderm by stage 7–8 while the former invade
the endoderm–mesoderm interface, becoming free invasive
mesenchymal cells which express both endothelial and mes-
enchymal markers (Linask, 1992; Linask and Lash, 1993;
Sugi and Markwald, 1996; Linask et al., 1997). Subse-
quently, the mesenchymal endocardial precursor cells as-
semble into a cord-like plexus at stage 8–9 from which a
definitive single epithelial tube of endocardium is directly
formed by stage 10 (De Ruiter et al., 1992; Sugi and Mark-
wald, 1996).
Importantly, all those characteristics of endocardiogen-
esis that occur in vivo, including (1) expression of the
endothelial and mesenchymal marker proteins; (2) forma-
tion of invasive mesenchymal precursor cells; and (3) their
assembly into vascular-like structures, are also recapitulated
in the collagen gel culture system when treated with endoderm
under appropriate serum-free conditions. Whereas, when
treated with control serum-free M199 alone, the precardiac
mesoderm remains as an aggregate on the surface of the
collagen gels and does not express endothelial and mesen-
chymal marker proteins (Sugi and Markwald, 1996). In the
present paper, we endeavor to extend these findings to the
identification of candidate molecules which potentially me-
diate the endocardiogenic effects of endoderm on mesoder-
mal explants.
TGFs are expressed in the endoderm at the critical
timing of endocardiogenesis and TGFs induce initiation
of endocardial precursor cell formation from mesoderm
In later stages of heart morphogenesis, the role of TGF
signaling in endocardial cells has been well documented,
particularly with regard to atrioventricular endothelial cell
transformation to mesenchymal cells (Potts and Runyan,
1989; Brown et al., 1996, 1999a; Nakajima et al., 1994,
1998; Ramsdell and Markwald, 1997). However, the role of
TGFs in early endocardiogenesis has received little atten-
tion. The present findings are the first to indicate that TGFs
induce endocardial precursor cell formation from undiffer-
entiated precardiac mesoderm.
Using RT-PCR, we found that TGF2, 3, and 4 (note
that chick TGF4 is a homologue of mammalian TGF1)
are expressed at mRNA level in isolated anterior lateral
endoderm at stage 5 (Fig. 2), the time point at which
endodermal induction of endocardial precursor cell forma-
tion is initiated in vivo (Sugi and Markwald, 1996). These
findings correlate with the expression of the Type II TGF
receptor, essential for all TGF signaling (Wrana et at.,
1994). Type II TGF receptor expression has been reported
in the developing endocardial endothelial cells (Barnett et
al., 1994; Brown et al., 1999b), which suggests that the
potential for TGF signaling exists during early endocardial
formation. Therefore, we added TGF ligands to the culture
medium to determine whether these growth factors have a
regulatory role in endocardiogenesis.
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Specifically, we observed that TGFs (1, 2, and 3)
were potent stimulators of endocardial precursor cell for-
mation as evidenced by the release of invasive mesenchy-
mal cells from mesodermal explants and their concomitant
expression of QH-1, as summarized in Fig. 7 and Table 1.
We found that mixtures of recombinant porcine TGFs (1,
2, and 3) (Figs. 3, 4, and 5) as well as individually added
TGF 1, 2, or 3 (data not shown) all promoted mesen-
chymal cell formation and QH-1 expression. Preliminary
experiments performed prior to the present study indicated
that invasive mesenchymal cell formation was elicited by
TGFs at concentrations as low as 0.5 ng/ml, i.e., 2/6 for
TGF1, 2/4 for TGF-2, and 3/6 for TGF3. However,
more stable induction was observed at the concentration of
3 ng/ml of each of the TGFs: 5/5 for TGF1, 4/5 for
TGF2, and 5/6 for TGF3. We did not observe significant
differences in effects among TGFs in QH-1-positive mes-
enchymal cell formation. This tendency remained the same
when the concentration of TGFs was increased to 10
ng/ml. Three ng/ml of TGFs is considered to be a biolog-
ical dosage and this concentration is lower than the level of
TGFs often used for transformation assays in endocardial
cushion tissue formation, e.g., 50 ng/ml (Nakajima et al.,
1994, 1998) or 10 ng/ml (Ramsdell and Markwald, 1997;
Boyer et al., 1999). Examining the results collectively, it is
unlikely that 3 ng/ml of TGFs used in the present paper
would cause over stimulation. The present findings suggest
that signaling effects of TGF 1, 2, and 3 are conserved
in their potential to induce formation of endocardial precur-
sor cells from cultured explants of precardiac mesoderm.
This notion is also consistent with the observation of pos-
sible redundancy in TGF knock out mice (Dickson et al.,
1995; Sanford et al., 1997), which did not reveal prominent
differences in endocardial formation. However, as endocar-
dial cells differentiate, their response to TGF ligand ap-
pears to become more specific—as exemplified by the AV
endocardium (Boyer et al., 1999). The present data, which
indicate that TGFs are potent mediators of endocardial
precursor cell formation, are further supported by our recent
results of inhibition of QH-1-positive invasive mesenchy-
mal cell formation by adding antibodies to type II TGF
receptor in endoderm–mesoderm coculture, which blocks
all of TGF signaling (data not shown).
Regarding BMP-2, this member of TGF superfamily
has also been reported to be expressed in the endoderm and
implicated in myocardial differentiation from precardiac
mesoderm (Lough et al., 1996; Schulthies et al., 1997;
Andre´e et al., 1998; Ehrman and Yutzey, 1999). BMP
receptors ActR-IIA (Stern et al., 1995) and BMPR-IB
(Lough and Sugi, 2000) are expressed in the precardiac
mesoderm, supporting the idea that endodermally derived
BMP-2 is involved in early heart formation. However, our
present data revealed distinct differences between the ef-
fects of TGFs and BMPs in endocardial precursor cell
formation. Differential effects of the TGFs and BMP-2
have also been reported in myocardial differentiation in the
epiblast and in the precardiac mesoderm (Ladd et al., 1998).
Since BMP-2 did not support either expression of endothe-
lial marker protein or formation of mesenchyme, it would
suggest that, prior to formation of a definitive heart tube, the
role of BMPs may be directed at promoting or sustaining
myocardial cell formation and/differentiation (Lough et al.,
1996; Schulthies et al., 1997; Andre´e et al., 1998; Reiter et
al., 2001).
VEGF is a potent stimulator of endothelial epithelium
formation but not endocardial precursor mesenchymal
cell formation
VEGF is another potent vasculogenic molecule, which
we found to have a significant role in endocardiogenesis. As
summarized in Fig. 7 and Table 1, one important finding
was that exogenously added VEGF165 did not induce mes-
enchymal cell formation but rather induced a monolayer of
epithelial cells to grow out from precardiac mesoderm,
which expressed perinuclear staining for the endothelial
marker QH-1 (Figs. 3c, 4c, and 4h). Most interestingly,
when VEGF was added together with TGFs, the mesoder-
mal explants created cord-like, vascular structures within
the three-dimensional framework of the collagen gels as
occurs in vivo during formation of the endocardial tube
(Sugi and Markwald, 1996). VEGF acts by stimulating
members of a family of receptor tyrosine kinases that in-
clude VEGFR-2 and VEGFR-1. VEGFR-2 is the earliest
receptor expressed in a subset of mouse (Yamaguchi et al.,
1993) and quail mesoderm (Eichmann et al, 1998).
VEGFR-1 is expressed in endothelial precursor cells in the
mesoderm at slightly later stages and in endothelial cells
that have formed vascular tube (Yamaguchi et al., 1993).
Mice homozygous for VEGF gene disruption die by ED10.5
(Carmeliet et al., 1996) or ED11.5 (Ferrara et al., 1996).
Disruption of the gene for VEGFR-2 seems to interfere with
early formation of endothelial precursor cells of both blood
vessels and hearts as well as hematopoietic cells, leading to
early embryonic lethality (ED8.5–9.0) (Shalaby et al.,
1995). Disruption of the gene for VEGFR-1 does not impair
early formation of endothelial cells but seems to interfere
with their later differentiation into vascular structures (Fong
et al., 1995). These findings suggest that VEGF, acting
through two different VEGF receptors, has two different
developmental roles: one early in endothelial lineage deter-
mination/formation (angioblast formation) and one later in
endothelial cell differentiation/endothelial lumen formation
(vasculogenesis). In this context, the data we obtained from
our collagen gel culture assays of precardiac mesoderm
treated with VEGF165 correlated closely with both potential
roles for VEGF, e.g., inducing lineage determination (QH-1
expression) and later differentiation/lumen formation (epi-
thelialization of angioblasts). Our culture data also compare
favorably with that obtained by microinjection of VEGF165
into parasomitic regions, which induced cell protrusive ac-
tivity and fusion of preformed vascular structures called
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“polygons” into larger vessels (Drake and Little, 1996;
Drake et al., 2000). Based on our data, we would propose
that VEGF mediates, in part, the effects of endoderm on
endocardial vasculogenesis through mechanisms that pro-
mote a “reversed” epithelial–mesenchymal transformation
in which free mesenchymal endocardial precursor cells (an-
gioblasts) become epithelialized to form a definitive endo-
cardially lined cardiac tube.
FGFs are thought to regulate endothelial marker protein
expression in quail blasto disc cultures (Flame and Risau,
1992). Angioblast induction and vessel formation and pat-
terning have also been reported when FGF protein-soaked
beads were implanted into noncardiogenic somitic mesoder-
mal regions of stage 10 quail embryos (Cox and Poole,
2000). Consistent with Flam and Risau (1992) and Cox and
Poole (2000), our present study also indicated that FGF-2
induced endothelial marker QH-1 expression. However,
Flame and Risau (1992) used blasto disc cultures at much
earlier stages than those that we studied, and they did not
address invasive mesenchymal cell formation, which is the
initial step of endocardial precursor cell formation. Cox and
Poole (2000) used stage 10 quail embryos in which endo-
cardial precursor cells had already been formed and had
assembled into the heart tube. Our culture assay system
utilized stage 5 anterior lateral plate mesoderm that strictly
adhered to the endocardial fate map (Fig. 1). Rigorous
adherence to the fate map is essential as the heart field may
not be fully defined by the expression of any known em-
bryonic genes at stage 5 (Eisenberg, 2002). It must be
emphasized that at stage 5 there are no detectable in vivo
signs of endocardial precursor cells in terms of expression
of endothelial/angioblast marker protein, QH-1. The initial
expression of QH-1 marker protein is detected only after
stage 7 (Coffin and Poole, 1988; Sugi and Markwald,
1996). Therefore, our experiments addressed regulation of
the initial emergence of the endocardial precursor cells from
undifferentiated mesoderm, while experiments conducted
after the emergence of the angioblasts (Cox and Poole,
2000) addressed regulation of differentiation and/or prolif-
eration of angioblasts already determined to be in an endo-
thelial lineage. This is further suggested by Pardanaud and
Lievre (1999) who indicated that endoderm and selected
growth factors induced formation of hemangiopoetic cells
in the associated mesoderm at stages 13–16, much later than
the stage (stage 5) we studied in the present report. Our
careful examination of each growth factor by using precar-
diac mesodermal explants from stage 5 quail embryos re-
vealed that FGF-2 and VEGF induced expression of the
endothelial marker, QH-1, but did not induce invasive mes-
enchymal cell formation, which is an essential and initial
step of endocardial precursor cell formation. Conversely,
TGFs induced invasive mesenchymal formation and QH-1
endothelial marker expression. We conclude that our find-
ings most likely address the initial steps of cardiac angio-
blast formation events.
Regarding lineage determination by the growth factors, it
has not been made clear whether endocardial cells are de-
rived from a separate lineage from cells that comprise the
lining of the vascular endothelium and if different mecha-
nisms are involved. Recent evidence indicates that endocar-
dial endothelial cells are biochemically distinct from cells
that comprise the endothelium of blood vessels. For exam-
ple, expression of the transcription factor, nuclear factor of
activated T cells (NFATc1), is restricted to endocardial
endothelial cells and that NFATc1 mRNA in murine pre-
cardiac mesoderm at ED 7.5 (de la Pompa et al., 1998) may
mark cells specified to an endocardial lineage. NFATc1 null
mice fail to develop normal cardiac valves and septa, struc-
tures that contain the progeny of endocardial endothelial
cells and die at ED 13.5 (de la Pompa, 1998; Ranger et al.,
1998). NFATc3 and NFATc4 mutant mice die around ED11
with generalized defects of vessel assembly as well as
excessive and disorganized growth of vessels, which closely
resemble the phenotype of calcineurin B (CnB) mutant mice
(Graef et al., 2001), while NFATc1 mutant mice have no
discernible defects in angiogenesis (de la Pompa, 1998;
Ranger et al., 1998). These data suggest different roles for
each NFATc gene in endocardiogenesis and vessel angio-
genesis/vasculogenesis and further suggest the possibility
that endocardial and vessel endothelial cells are regulated
through different molecular pathways. Other evidence that
endocardial and vascular endothelial cells are distinct is
provided by the zebrafish mutant cloche, which lacks an
endocardial tube but not a blood vessel endothelium
(Stainier et al., 1995); subsequent findings that cloche acts
upstream of VEGFR-2 (Liao et a., 1997) further raise the
possibility that the formation of endocardial and vascular
endothelial cells is regulated by different signaling path-
ways. In this context, studies which address interactions
between endodermal growth factors and endocardial spe-
cific factors like NFATc1 could shed further light on the
mechanisms underlying early endocardiogenesis.
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